'I don't understand the question': White House spokeswoman baffled by Newsmax reporter's scientific

[Jilly_in_VA]

A Newsmax reporter on Friday left White House Deputy Press Secretary Karine Jean-Pierre baffled after asking a bizarre question about whether White House officials were personally conducting tests to make sure the delta variant had become the dominant strain of the novel coronavirus.

During the Friday White House press briefing, the Newsmax reporter asked, "How do you know test whether it's the dominant strain in the area when people just test whether they're COVID-positive?"

"We don't test it, we listen to public health and scientists and they tell us it's the delta variant," Jean-Pierre said.

The reporter then asked if the health experts explained their "process" for testing.

https://www.rawstory.com/newsmax-reporter/
________________________________________
These guys remind me of the 90s TV show "You Can't Do That on Television" and the teacher who Plaintively asked "Where do they get them, and why do they keep sending them to me?"

[Takket]

1. why is newsmax allowed in the briefing room?

[marie999]

2. How does newsmax even find the briefing room?

[GPV]

5. LOL

[Jilly_in_VA]

3. I suppose

because unlike tfg, Biden doesn't ban anybody.

[Maru Kitteh]

4. X1000

[lapucelle]

6. This White House doesn't do it's own research on facebook the way TFG's WH did.

Genomic sequencing is conducted and that data is reported to the CDC.

Published SARS-CoV-2 Sequences
As the pandemic progresses and new variants of SARS-CoV-2 have emerged, it is critical for the United States and other countries to sequence and analyze virus samples. Sequence data provides us with information about the genetic diversity, spread, and evolution of the virus to assess the impact on current efforts to control the pandemic, including the impact on vaccines. CDC is enhancing sequencing efforts by collaborating with state and local public health laboratories (PHLs) and partners, such as the Association of Public Health Laboratories, to increase the number of specimens that are sequenced as part of the National SARS-CoV-2 Strain Surveillance (NS3) program. CDC is also increasing sequencing capacity through contracts with commercial diagnostic laboratories. These collaborative sequencing efforts will provide a better understanding of the SARS-CoV-2 variants that exist in the US.

https://covid.cdc.gov/covid-data-tracker/#published-covid-sequences